Login
Israel-Hamas Conflict
Juneteenth
Boxing
Artificial Intelligence
Social Media
Soccer
War
Infrastructure
Corruption
Education
Donald Trump
European Union
Stock Markets
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Summary by Post Register
BURLINGTON, Mass.--(BUSINESS WIRE)--Jun 18, 2025-

2 Articles

All
Left
Center
1
Right
Post RegisterPost Register
Center

MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

BURLINGTON, Mass.--(BUSINESS WIRE)--Jun 18, 2025-

Read Full Article
EuropaWire.euEuropaWire.eu

Neoclease Wins Merck’s 2025 Biotech Grant for AI-Powered Gene Therapies Targeting Parkinson’s and Genetic Disorders

Neoclease Wins Merck’s 2025 Biotech Grant for AI-Powered Gene Therapies Targeting Parkinson’s and Genetic Disorders (IN BRIEF) Merck has awarded its 2025 North American Advance Biotech Grant to Neoclease, a Boston-based startup developing AI-designed gene-editing therapies for Parkinson’s disease and other monogenic disorders. Neoclease will benefit from Merck’s technologies, contract testing, regulatory guidance, and hands-on training through i…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Post Register broke the news in on Wednesday, June 18, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Parkinson's Disease icon

Parkinson's Disease

Startups icon

Startups

Merck icon

Merck

Burlington, Massachusetts icon

Burlington, Massachusetts

News
For You
SearchBlindspotLocal